UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )
AMPLIDYNE, INC.
----------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------
(Title of Class of Securities)
032103103
--------------
(CUSIP Number)
Edward B. Winslow, Esq.
Jacobs Persinger & Parker
77 Water Street, New York, New York 10005 212-344-1866
-----------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
March 18, 1999
------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box / /.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7(b) for
other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any
subsequent amendment containing information which would alter disclosures
provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
--------------------------------------------------------------------------------
2
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Jerome Belson
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 669,074
REPORTING PERSON ------------------------------------------
WITH (8) SHARED VOTING POWER
---
------------------------------------------
(9) SOLE DISPOSITIVE POWER
669,074
------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
669,074 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN /X/
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.4%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
3
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
The Jerome Belson Foundation, f/k/a The Joseph Belsky
Foundation
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 88,000
REPORTING PERSON ------------------------------------------
WITH (8) SHARED VOTING POWER
---
------------------------------------------
(9) SOLE DISPOSITIVE POWER
88,000
------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
88,000 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.1%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
4
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Marjorie Belson
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 10,000
REPORTING PERSON -------------------------------------------
WITH (8) SHARED VOTING POWER
---
-------------------------------------------
(9) SOLE DISPOSITIVE POWER
10,000
-------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
10,000 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
5
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Brianne Goldstein
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 50,000
REPORTING PERSON -------------------------------------------
WITH (8) SHARED VOTING POWER
---
-------------------------------------------
(9) SOLE DISPOSITIVE POWER
50,000
-------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
50,000 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.6%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
6
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Joshua Goldstein
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 20,400
REPORTING PERSON -------------------------------------------
WITH (8) SHARED VOTING POWER
---
-------------------------------------------
(9) SOLE DISPOSITIVE POWER
20,400
-------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
20,400 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.3%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
7
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Toby Goldstein
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 25,000
REPORTING PERSON ------------------------------------------
WITH (8) SHARED VOTING POWER
---
------------------------------------------
(9) SOLE DISPOSITIVE POWER
25,000
------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
25,000 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.3%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
8
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Jaclyn Belson
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 10,000
REPORTING PERSON ------------------------------------------
WITH (8) SHARED VOTING POWER
---
------------------------------------------
(9) SOLE DISPOSITIVE POWER
10,000
------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
10,000 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
9
SCHEDULE 13D
CUSIP No. 032103103
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON.
Jonathan Belson
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A (a) / /
MEMBER OF A GROUP* (b) /X/
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL / /
PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
Not applicable.
--------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH 20,000
REPORTING PERSON ------------------------------------------
WITH (8) SHARED VOTING POWER
---
------------------------------------------
(9) SOLE DISPOSITIVE POWER
20,000
------------------------------------------
(10) SHARED DISPOSITIVE POWER
---
--------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
20,000 shares
--------------------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN / /
ROW (11) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.3%
--------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
10
SCHEDULE 13D
ITEM 1. SECURITY AND ISSUER
This Schedule 13D relates to shares of Common Stock, par value $.0001
per share (the "Common Stock"), of Amplidyne, Inc. whose Ticker Symbol is AMPD
(the "Company"), whose principal executive office is located at 59 LaGrange
Street, Raritan, New Jersey 08869.
ITEM 2. IDENTITY AND BACKGROUND
The names and addresses of the persons filing this Schedule are as
follows:
Jerome Belson, whose address is Jerome Belson Associates, Inc., 495
Broadway, New York, NY 10012. Jerome Belson is Chairman of the Board of Jerome
Belson Associates, Inc., a real estate management company; Chairman of the Board
of WE Magazine (magazine on lifestyle of people with disabilities); and
President of Associated Builders and Owners of Greater New York, Inc.
The Jerome Belson Foundation, a New York not-for-profit corporation
formerly known as The Joseph Belsky Foundation (the "Foundation"), is organized
for educational, charitable and scientific purposes. The Foundation's address is
495 Broadway, New York, New York 10012. Jerome Belson is the President of the
Foundation. Certain information concerning the officers of the Foundation is set
forth in Annex I hereto.
Marjorie Belson is the daughter-in-law of Jerome Belson. Her address is
315 Ocean Parkway - Apt. 1P, Brooklyn, NY 11218.
Brianne Goldstein is the daughter of Jerome Belson. Her address is 22 A
Putnam Green, Greenwich, CT 06830.
Joshua Goldstein is a grandson of Jerome Belson. His address is 5516
South Robertson - Apt. A., New Orleans, LA 70115.
Toby Goldstein is a granddaughter of Jerome Belson. Her address is 22 A
Putnam Green, Greenwich, CT 06830.
11
Jaclyn Belson is a granddaughter of Jerome Belson. Her address is 444
East 86th Street - Apt. 12G, New York, NY 10028.
Jonathan Belson is a grandson of Jerome Belson. His address is 444 East
86th Street - Apt. 12G, New York, NY 10028.
None of Jerome Belson, the Foundation, Marjorie Belson, Brianne
Goldstein, Joshua Goldstein, Toby Goldstein, Jaclyn Belson, or Jonathan Belson
has, and to the best of the knowledge of Jerome Belson, the Foundation, Marjorie
Belson, Brianne Goldstein, Joshua Goldstein, Toby Goldstein, Jaclyn Belson and
Jonathan Belson no person listed on Annex I has, during the past five years been
(i) convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors), or (ii) a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction as a result of which such
individual or entity was or is subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation with respect to
such laws.
Jerome Belson, Marjorie Belson, Brianne Goldstein, Joshua Goldstein,
Toby Goldstein, Jaclyn Belson, and Jonathan Belson are United States citizens.
The Foundation is a New York domestic not-for-profit corporation.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The aggregate purchase price of the 669,074 shares of Common Stock of
the Company (inclusive of 50,000 shares of Common Stock which there is a right
to acquire in accordance with warrants that are currently exercisable) purchased
by Jerome Belson is $2,027,190 including brokerage commissions. Jerome Belson
used his personal funds to purchase such shares of Common Stock.
The aggregate purchase price of the 88,000 shares of the Common Stock
of the Company purchased by the Foundation was $509,533, including brokerage
commissions. The Foundation used funds from its capital to purchase such shares
of Common Stock.
12
The aggregate purchase price of the 10,000 shares of the Common Stock
of the Company purchased by Marjorie Belson was $28,366, including brokerage
commissions (but excluding 1,500 shares received by gift from Jerome Belson on
March 6, 2000 which were previously purchased by Mr. Belson at a cost of
$10,380.) Marjorie Belson used her personal funds to purchase such shares of
Common Stock.
The aggregate purchase price of the 50,000 shares of the Common Stock
of the Company purchased by Brianne Goldstein was $135,074, including brokerage
commissions (but excluding 1,500 shares received by gift from Jerome Belson on
March 6, 2000 which were previously purchased by Mr. Belson at a cost of
$10,380.) Brianne Goldstein used her personal funds to purchase such shares of
Common Stock.
The aggregate purchase price of the 20,400 shares of the Common Stock
of the Company purchased by Joshua Goldstein was $57,130, including brokerage
commissions (but excluding 1,500 shares received by gift from Jerome Belson on
March 6, 2000 which were previously purchased by Mr. Belson at a cost of
$10,380.) Joshua Goldstein used his personal funds to purchase such shares of
Common Stock.
The aggregate purchase price of the 25,000 shares of the Common Stock
of the Company purchased by Toby Goldstein was $74,378, including brokerage
commissions (but excluding 1,500 shares received by gift from Jerome Belson on
March 6, 2000 which were previously purchased by Mr. Belson at a cost of
$10,380.) Toby Goldstein used her personal funds to purchase such shares of
Common Stock.
The aggregate purchase price of the 10,000 shares of the Common Stock
of the Company purchased by Jaclyn Belson was $27,230, including brokerage
commissions (but excluding 1,500 shares received by gift from Jerome Belson on
March 6, 2000 which were previously purchased by Mr. Belson at a cost of
$10,380.) Jaclyn Belson used her personal funds to purchase such shares of
Common Stock.
The aggregate purchase price of the 20,000 shares of the Common Stock
of the Company purchased by Jonathan Belson was $53,584, including brokerage
commissions (but excluding 1,500 shares received by gift from Jerome Belson on
March 6, 2000 which were previously purchased by Mr. Belson at a cost of
$10,380.) Jonathan Belson used his personal funds to purchase such shares of
Common Stock.
13
ITEM 4. PURPOSE OF TRANSACTION.
The purchases of the shares reported in this Schedule 13D were made for
the purpose of making an investment in the Company. Consistent with such
purpose, Jerome Belson has had and expects to continue to have discussions with
management of the Company concerning the Company and the investment of persons
making this filing therein. Jerome Belson may also engage in such discussions
with other shareholders of the Company.
The persons making this filing may, in the future, purchase additional
shares of the Common Stock of the Company depending on the price of the shares
and circumstances at the time of such acquisitions, if any, are made.
Alternatively, any of the persons making this filing may at any time determine
to realize on such person's investment in the securities of the Company through
their sale.
The persons making this filing have no present plans or proposals to
effect one or more of the transactions enumerated in paragraphs (b) to (j) of
ITEM 4 of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) As of the close of business on August 24, 2001, Jerome Belson, The
Foundation, Marjorie Belson, Brianne Goldstein, Joshua Goldstein, Toby
Goldstein, Jaclyn Belson and Jonathan Belson beneficially owned 669,074
(inclusive of 50,000 warrants), 88,000, 10,000, 50,000, 20,400, 25,000, 10,000,
and 20,000 shares of Common Stock of the Company, respectively, for an aggregate
of 892,474 shares representing approximately 11.2% of the aggregate of the
outstanding Common Stock of the Company (based on information from the Company's
Form 10-QSB for the period ended June 30, 2001, which indicates 7,892,661 shares
of Common Stock outstanding).
(b) Under the definition of beneficial ownership in Rule 13d-3 under
the Securities Exchange Act of 1934 (the "Act"), Jerome Belson may also be
deemed to be a beneficial owner of the 88,000 shares of the Company owned by The
Jerome Belson Foundation because Mr. Belson, in his capacity as President of the
Foundation, might be deemed to
14
have the power to dispose of and vote the shares of the Company owned by the
Foundation. However, neither the filing of this statement nor any of its
contents shall be deemed to be an admission that Mr. Belson is the owner of
the shares of the Company beneficially owned by the Foundation for purposes
of Section 13(d) of the Act or for any other purpose.
(c) Each of Jerome Belson, the Foundation, Marjorie Belson, Brianne
Goldstein, Joshua Goldstein, Toby Goldstein, Jaclyn Belson and Jonathan Belson
has the sole power to vote or to direct the vote and sole power to dispose of or
direct the disposition of the shares of Common Stock of the Company owned by
each of them.
(d) Between June 15, 2001 and the date hereof none of the persons
filing this Schedule 13D has effected any transactions in the Common Stock
of the Company except:
(i) On June 29, 2001 Jerome Belson purchased from the Company
in a privately negotiated transaction 100,000 shares of the Common Stock and
50,000 warrants each for the purchase of one share of Common Stock exercisable
at $3.00 per share for a purchase price per share of Common Stock and one-half
warrant of $1.50; and
(ii) The Foundation purchased shares of the Common Stock of
the Company in the open market on the NASDAQSC National Market as described
below.
DATE SHARES PURCHASED PRICE PER SHARE
---- ---------------- ---------------
6/18/01 500 $1.73
6/19/01 500 1.57
6/19/01 500 1.63
6/19/01 500 1.60
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO THE SECURITIES OF THE ISSUER
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 1: Written agreement relating to the filing of a joint
acquisition statement.
15
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
the undersigned certify that the information set forth in this statement is
true, complete and correct.
Dated: August 27, 2001
/s/ Jerome Belson
----------------------------
Jerome Belson
The Jerome Belson Foundation
By: /s/ Jerome Belson
----------------------------
Jerome Belson, President
/s/ Marjorie Belson
----------------------------
Marjorie Belson
/s/ Brianne Goldstein
----------------------------
Brianne Goldstein
/s/ Joshua Goldstein
----------------------------
Joshua Goldstein
/s/ Toby Goldstein
----------------------------
Toby Goldstein
/s/ Jaclyn Belson
----------------------------
Jaclyn Belson
/s/ Jonathan Belson
----------------------------
Jonathan Belson
16
EXHIBIT 1
The undersigned hereby agree that the Schedule 13D and any amendments
thereto, filed by Jerome Belson, The Jerome Belson Foundation, Marjorie Belson,
Brianne Goldstein, Joshua Goldstein, Toby Goldstein, Jaclyn Belson and Jonathan
Belson under the Securities Exchange Act of 1934, (the "Act") reporting the
beneficial ownership of shares of Common Stock of Amplidyne, Inc. may be filed
with the Securities and Exchange Commission pursuant to Rule 13d-1(k)(1) under
the Act on behalf of the undersigned.
Dated: August 27, 2001
/s/ Jerome Belson
----------------------------
Jerome Belson
The Jerome Belson Foundation
By: /s/ Jerome Belson
----------------------------
Jerome Belson, President
/s/ Marjorie Belson
----------------------------
Marjorie Belson
/s/ Brianne Goldstein
----------------------------
Brianne Goldstein
/s/ Joshua Goldstein
----------------------------
Joshua Goldstein
/s/ Toby Goldstein
----------------------------
Toby Goldstein
/s/ Jaclyn Belson
-----------------------------
Jaclyn Belson
/s/ Jonathan Belson
-----------------------------
Jonathan Belson
17
ANNEX I
The following is a list of the officers of The Jerome Belson
Foundation:
PRINCIPAL OCCUPTION
NAME AND POSITION AND BUSINESS ADDRESS
Jerome Belson Chairman of the Board of Jerome
- President Belson Associates, Inc.
495 Broadway
New York, New York 10012
Maxine Belson Housewife
- Vice President 197 Rugby Road
Brooklyn, New York 11226
I. Victor Belson Attorney
- Vice President Belson, Perlman & Szuflita
400 Madison Avenue
New York, New York 10017
Brianne Goldstein Housewife
- Treasurer 22 A Putnam Green
Greenwich, CT 06830
Ruth Kessler Executive Secretary
- Secretary Belson Associates, Inc.
495 Broadway
New York, New York 10012
All of the above named individuals are citizens of the United States.
18